Your session is about to expire
← Back to Search
Rucaparib for Endometrial Cancer (EndoBARR Trial)
EndoBARR Trial Summary
This trial is testing a combination of drugs to treat endometrial cancer that has come back or is getting worse.
- Endometrial Cancer
- Uterine Carcinosarcoma
EndoBARR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.EndoBARR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You had a heart attack or unstable chest pain within the past year.You have trouble taking medicine by mouth or keeping pills down.You have moderate or severe peripheral vascular disease.You have a severe wound, ulcer (including in your stomach or intestines), or bone fracture that is not healing properly.You have a history of or signs of brain-related diseases, like brain tumors or uncontrolled seizures, or if there are any cancer cells that have spread to your brain.You have a significant heart condition that could affect your health during the study. This includes:You have a history of dangerous heart rhythm problems or have needed medication to control irregular heartbeats, except for a specific type of irregular heartbeat called atrial fibrillation that is well controlled with medication.You have a history of blocked arteries or blood clots.
- Group 1: Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people have signed up to participate in this medical research?
"As of 4/4/2022, this clinical trial is not currently seeking more candidates. This study was first posted on 7/19/2019 and has had no recent updates. However, there are 317 other trials for mixed tumor, mullerian patients and 674 studies involving Atezolizumab that are still looking for participants."
For what purpose is Atezolizumab most frequently prescribed?
"Atezolizumab can be used to fight ovarian cancer that has returned despite platinum-based treatment, as well as other malignant neoplasms and peritoneal cancers."
What are some other experiments that have been done using Atezolizumab?
"Atezolizumab was first studied in 2004 at Memoral Sloan Kettering Basking Ridge. So far, 1091 trials have been completed with 674 currently active. New york City has a high density of these ongoing studies."
Has Atezolizumab received government backing for public use?
"Atezolizumab's efficacy is unproven, but it has received a score of 2 due to prior clinical data suggesting that it is safe."
Is patient enrollment still open for this clinical trial?
"This trial, as indicated on clinicaltrials.gov, is not currently looking for patients but was most recently updated on 4/4/2022. There are 991 other trials that are currently recruiting patients."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger